Home » Aptalis Launches Viokace Tablets in U.S.
Aptalis Launches Viokace Tablets in U.S.
Aptalis Pharma, a specialty pharmaceutical company, has announced the commercial availability of Viokace (pancrelipase) tablets in the U.S. Viokace, in combination with a proton pump inhibitor, is indicated in adults for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May